Top Markets
Coin of the day
Immage Biotherapeutics Corp. Immage Biotherapeutics Corp.

Immage Biotherapeutics Corp.

IMMG
Rank in Stocks #41597
Presently, Immage Biotherapeutics Corp. lacks substantial business operations.... Presently, Immage Biotherapeutics Corp. lacks substantial business operations. Historically, its endeavors centered on the creation of cutting-edge immunotherapy biologics designed to combat diverse cancer types across the United States. Established in 2012, the entity was initially known as Epicure Charcoal, Inc., rebranding to Immage Biotherapeutics Corp. in June 2015. Its corporate headquarters are situated in Bethesda, Maryland, and it operates as a subsidiary of Coventry International Limited.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$15.17K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Immage Biotherapeutics Corp. (IMMG)
Operating Margin for Immage Biotherapeutics Corp. (IMMG)
Operating Margin as of 2026 TTM: 0.00%
According to Immage Biotherapeutics Corp. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Immage Biotherapeutics Corp. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.